Phase 3 Coronavirus Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC3,082 enrolled222 locationsNCT06667700
Recruiting
Phase 3
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
SARS-CoV-2 infectionCOVID-19Long COVID+1 more
Wes Ely550 enrolled17 locationsNCT06631287
Recruiting
Phase 3
Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms
COVID19SARS-Associated Coronavirus
Cardresearch7,819 enrolled12 locationsNCT04727424
Recruiting
Phase 3
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
COVID19CoronavirusCoronavirus Infection+2 more
West Virginia University240 enrolled1 locationNCT04376034